GRNE Stock | News | Quote | Stock Forum | Monday, October 21,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Green Endeavors, Inc. GRNE Company Overview 

Stock Message Board http://investorshangout.com/search?q=GRNE&...mp;yt1=Go!

Last Updated: Monday, October 21, 2013 7:35:49 PM

Green Endeavors, Inc. GRNE Current Price and Quotes
Last Price 0.0094
Previous Close 0.0086 Open 0.0094
Daily Range 0.0099 - 0.0077 52wk Range 2.50 - 0.0026
Volume 2,224,501 Dividend N/A
Average Vol (3m) 2,384,801 Yield N/A
Green Endeavors, Inc. GRNE
Company Information

59 West 100 South
Suite 200
Salt Lake City, UT

Website: http://www.green-endeavors.com
Phone: 801-575-8073

Green Endeavors, Inc. GRNE
Green Endeavors (GRNE) currently operates two salons that sell Aveda products exclusively. GRNE's flagship salon is named Landis Lifestyle Salon which is an Aveda Lifestyle Salon. The flagship location has 20 chairs and gross annual revenues of approximately $2M. GRNE's long term plans will include national expansion. GRNE's initial expansion plans will be limited to a 50 mile radius of Salt Lake City, Utah which would include up to 6 salons. For more information, please visit www.green-endeavo...



Green Endeavors, Inc. GRNE
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Jun 30, 2013 10-Q
CIK 0001487997
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 7200 - Services-Personal Services
Incorporated In: UT, USA
Year of Inc. 2002
Employees 50 a/o Dec 31, 2009
Company Officers/Contacts

Richard Surber President, CEO, CFO
Company Directors

Richard Surber
Company Notes

Formerly=Green Endeavors, Ltd. until 8-2010
Formerly=Net2Auction, Inc. until 8-07
Service Providers

Auditor/Accountant
Sadler, Gibb & Associates, LLC
170 South Main Street
Sutie 1120
Salt Lake City, UT, 84101
United States

Legal Counsel
Michael Golightly
59 W. 100 South
Salt Lake City, UT, 84101-1831
United States

Investor Relations Firm
NFC Corp.
105 Centre Street
Dover, MA, 02030
United States


Green Endeavors, Inc. GRNE
GRNE Security Details

Share Structure

Market Value1 Not Available
Shares Outstanding Not Available
Float Not Available
Authorized Shares Not Available
Par Value  0.001
Shareholders

Shareholders of Record 3,500 a/o Dec 20, 2012
Security Notes

Capital Change=shs decreased by 1 for 5 split Pay date=08/03/2007.
Capital Change=shs increased by 5 for 1 split Ex-date=09/03/2010. Rec date=08/23/2010. Pay date=09/02/2010.
Capital Change=shs decreased by 1 for 200 split. Pay date=04/10/2013.
Short Selling Data

Short Interest 0 (-100%)
Jul 15, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

Pacific Stock Transfer Co.

Green Endeavors, Inc. GRNE Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 3,149 2,814 2,251 2,044
Cost of Revenue 1,843 1,615 1,305 1,157
Gross Profit 1,306 1,200 946 887
Operating Expenses

Research and Development - - - -
Sales, General and Admin. 1,415 1,051 960 656
Non-Recurring Items - - - -
Other 124 94 77 114
Operating Income (233) 55 (91) 117
Income From Continuing Operations

Add'l Income/Expense Items (136) 92 359 (240)
Earnings Before Interest and Tax (370) 146 267 (123)
Interest Expense 445 423 254 262
Earnings Before Tax (814) (276) 14 (385)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (814) (276) 14 (385)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (814) (276) 14 (385)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (814) (276) 14 (385)

Green Endeavors, Inc. GRNE Recent News

Oct 21, 2013 Landis Lifestyle Salons Recognized as One of the Country's Top 200 Salons for Its Recruitment and Training Program
Oct 14, 2013 GRNE Reports Revenues of $2.65M and $878K for the Nine and Three Months Ended September 30, 2013
Oct 11, 2013 GRNE Enters Into Agreement to Satisfy Convertible Note Holder
Oct 7, 2013 GRNE Reports Revenue of $274,346 for September 2013; Up 3.97% Over September 2012
Oct 4, 2013 Nexia Submits Legal Opinion to DTCC for Removal of Chill
Oct 3, 2013 GRNE Reports Revenue of $314,070 for August 2013; Up 13.1% Over August 2012
Oct 2, 2013 Green Endeavors Ranked Among Utah's Top Public Companies for 2012
Oct 1, 2013 GRNE's 2nd Quarter Form 10Q Filing Shows Income From Operations on Increased Revenues
Sep 10, 2013 GRNE Reports Revenue of $289,966 for July 2013; Up 19.96% Over July 2012
Aug 28, 2013 GRNE's 1st Quarter Form 10Q Filing Shows Marked Financial Improvements


GRNE Green Endeavors, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=GRNE&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/GRNE/quote
Stock Chart http://www.otcmarkets.com/stock/GRNE/chart
Company Info http://www.otcmarkets.com/stock/GRNE/company-info
Recent News http://www.otcmarkets.com/stock/GRNE/news
Financials http://www.otcmarkets.com/stock/GRNE/financials
Filings and Disclosure http://www.otcmarkets.com/stock/GRNE/filings
Short Sales http://www.otcmarkets.com/stock/GRNE/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/GRNE/insider-transactions
Research Reports http://www.otcmarkets.com/stock/GRNE/research
Summary http://finance.yahoo.com/q?s=GRNE
Historical Prices http://finance.yahoo.com/q/hp?s=GRNE+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=GRNE
Basic Chart http://finance.yahoo.com/q/bc?s=GRNE+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=GRNE+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=GRNE+Headlines
Press Releases http://finance.yahoo.com/q/p?s=GRNE+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=GRNE+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=GRNE+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=GRNE+Industry
Major Holders http://finance.yahoo.com/q/mh?s=GRNE+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=GRNE+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=GRNE+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=GRNE
Balance Sheet http://finance.yahoo.com/q/bs?s=GRNE
Cash Flow http://finance.yahoo.com/q/cf?s=GRNE+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/GRNE
Market Watch http://www.marketwatch.com/investing/stock/GRNE
Bloomberg http://www.bloomberg.com/quote/GRNE:US
Morningstar http://quotes.morningstar.com/stock/s?t=GRNE
Bussinessweek http://investing.businessweek.com/research/st...icker=GRNE
Barchart http://www.barchart.com/quotes/stocks/GRNE
OTC Short Report http://otcshortreport.com/index.php?index=GRNE
Investopedia http://www.investopedia.com/markets/stocks/GRNE/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 92

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 69

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 147

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 143

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 303

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 185

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 292

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 96

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 146

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 239

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading

Top 5 Most Recently Viewed Articles

Heights Wellness Retreat: A Bold Step Towards Holistic Wellness

Updated Category News Views 227

Heights Wellness Retreat: A New Era of Wellness In a landmark announcement during their annual summit, Massage Heights unveiled a significant transformation that redefines their brand identity. The brand, known for its commitment to wellness over the past two decades, will now operate under the name Heights Wellness Retreat. This evolution is more than just a new name; it...

Continue Reading
GeneDx Strengthens Leadership with New COO Appointment

Updated Category News Views 168

GeneDx Welcomes Bryan Dechairo as Chief Operating Officer GeneDx (NASDAQ: WGS) has made headlines with the appointment of Bryan Dechairo as its new Chief Operating Officer. This strategic decision aims to enhance operations and drive the company’s next phase of growth. Enhancing Operations for Future Success As COO, Dechairo will oversee critical areas including Product...

Continue Reading
FreightCar America to Share Q1 2025 Financial Results Soon

Updated Category News Views 130

FreightCar America Prepares for Q1 2025 Earnings Announcement FreightCar America, Inc. (NASDAQ: RAIL), a prominent player in the manufacturing of railroad freight cars, is gearing up to release its financial results for the first quarter of 2025. This important announcement is scheduled for after the market closes on a Monday, allowing investors and stakeholders to digest...

Continue Reading
Empowering Veterans: United Food Group's New Initiative

Updated Category News Views 129

United Food Group Unveils New Employment Initiative United Food Group, a noted developer and manufacturer of coffee equipment, powdered condiments, and beverages, has announced an innovative employment initiative designed to support wounded veterans and first responders. This program not only aims to empower these individuals but also provides them with specialized...

Continue Reading
US Futures Gain on Peace Talk Hopes Amid Market Developments

Updated Category News Views 206

U.S. Stock Futures Trend Upward U.S. stock futures saw an increase following the extended weekend, coming off a mixed trading day last Friday. The day off for Presidents Day allowed investors to reassess their positions. As a result, all four major indices posted gains in premarket trading. Investor Focus on Macro Conditions In today's trading, investors will closely...

Continue Reading